SBIR-STTR Award

High-Resolution Multi-Modality Endoscopic Imaging Probes for Diagnosing Rejection in Lung Transplant Recipients
Award last edited on: 11/15/2017

Sponsored Program
SBIR
Awarding Agency
NIH : NHLBI
Total Award Amount
$223,403
Award Phase
1
Solicitation Topic Code
NHLBI
Principal Investigator
Andrei Vertikov

Company Information

LX Medical Corporation

315 Oak Street
Westwood, MA 02090
   (781) 762-2569
   N/A
   www.lx-medical.com
Location: Single
Congr. District: 08
County: Norfolk

Phase I

Contract Number: ----------
Start Date: ----    Completed: ----
Phase I year
2017
Phase I Amount
$223,403
Lung transplantation is increasingly used to treat patients with end-stage lung diseases. Complications frequently occur with chronic allograft rejection causing most of late morbidity and mortality in lung transplant recipients. Pathological manifestations of chronic rejection mostly affect small airways or bronchioles in the lung, often progressing undetected until the patient presents with an irreversible decline in pulmonary function. There is an unmet need for safe and accurate methods to detect and classify earlier, sub-clinical lesions associated with subsequent development of chronic rejection in asymptomatic patients, to maximize preservation of lung function in these patients. The goal of this project is to build and evaluate a clinical instrument that is capable of 3D imaging of bronchioles and surrounding parenchyma to address this unmet need. With this instrument, clinicians will be able to identify, minimally-invasively, dimensional and structural changes of small airways and alveoli, and to detect vascular and fibrotic abnormalities in the airways. The instrument will rapidly scan many branches of sub-segmental bronchioles for reliable and accurate classification of early pathologies leading to chronic rejection to indicate earlier and more targeted therapeutic interventions. Our proposed instrument is based on a miniaturized flexible endobronchial imaging probe that combines multi-modality optical coherence tomography with autofluorescence imaging. This high resolution and high-capability imaging, recently developed by our academic collaborators, has been shown to accurately and rapidly visualize fine anatomical structures of small airways and alveoli, also identifying pulmonary vasculature and lung fibrosis. Towards the objective of developing and evaluating such a clinical instrument, we will first improve the existing prototypes (Aim 1) to enhance image features associated with relevant pathologies in the lung graft. We will validate the improved performance using test fixtures and live animals. Aim 2 is to evaluate the readiness of the improved instrument for human trials by conducting appropriate safety and performance tests for the device. In Aim 3, we will evaluate the multi-modality endobronchial imaging probe in clinical trials aimed at collecting a library of images of lung transplant patients and identifying diagnostic criteria in the image data for detection of abnormalities associated with chronic rejection of lung allograft. We will image asymptomatic patients during their regular post-transplant exams and patients with established lung transplant dysfunction. We will correlate relevant image features with lung function, histology and bronchoalveolar lavage findings, and other clinical parameters and clinical history in these two groups of patients.

Public Health Relevance Statement:
NARRATIVE Transplant rejection continues to be the main cause of the high mortality and morbidity of lung transplant recipients. In this project, we propose to develop and to evaluate in initial studies with human patients a clinical bronchiolescope – a novel medical device for accurate and safe diagnosis of early pathologies of small airways in the lung transplant. The bronchiolescope will utilize an innovative endobronchial imaging probe for minimally-invasive evaluation of bronchioles and surrounding lung tissue, detecting rejection-related lesions earlier and indicating treatments before lung transplant recipients develop airflow limitations, extending dysfunction-free survival for these patients.

Project Terms:
Address; Affect; allograft rejection; Anatomy; Animal Model; Animals; Back; base; Basement membrane; Biopsy; Blood Vessels; Bronchioles; Bronchoalveolar Lavage; Bronchoscopes; Caliber; Chronic; Classification; Clinical; Clinical Trials; Collagen; Data; design; Detection; Development; Devices; Diagnosis; Diagnostic; Diagnostic Imaging; Dimensions; Disease; disease diagnosis; Early Diagnosis; Endoscopy; Epithelium; Evaluation; flexibility; Functional disorder; Future; Goals; Graft Rejection; high resolution imaging; Histologic; Histology; Human; Image; Image Enhancement; imaging capabilities; imaging probe; improved; innovation; instrument; Lamina Propria; Lead; Lesion; Libraries; Lung; lung allograft; Lung diseases; lung imaging; lung lobe; lung preservation; Lung Transplantation; Measures; Medical Device; Methods; miniaturize; minimally invasive; Modality; Modification; Morbidity - disease rate; Morphologic artifacts; mortality; Mucous body substance; novel; Optical Coherence Tomography; Pathologic; Pathology; Patients; Performance; performance tests; Phase; Plasticizers; programs; Protocols documentation; prototype; Pulmonary Fibrosis; pulmonary function; Readiness; Recording of previous events; Research; Resolution; Respiratory physiology; safety testing; Scanning; small airways disease; Small Business Innovation Research Grant; Speed; Structure of parenchyma of lung; targeted treatment; Testing; Therapeutic Intervention; Thick; Thinness; Three-Dimensional Imaging; Translating; Transplant Recipients; Transplantation

Phase II

Contract Number: ----------
Start Date: ----    Completed: ----
Phase II year
----
Phase II Amount
----